LindaJeanBurnsMD
Oncology • Minneapolis, MNHematologic Oncology
Professor, Medicine, University of Minnesota Medical School
Are you Dr. Burns?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 82 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
University of Minnesota Physicians
516 Delaware Street SE PWB Fifth floor Clinic 5B
Minneapolis, MN 55455Phone+1 612-273-2800Fax+1 612-625-6919- Is this information wrong?
Summary
- Dr. Linda Burns, MD is an oncologist in Minneapolis, Minnesota. She is currently licensed to practice medicine in Minnesota and Iowa. She is affiliated with M Health Fairview University of Minnesota Medical Center and is a Professor at University of Minnesota Medical School.
Education & Training
University of Iowa Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 1984 - 1988- University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1981 - 1984
University of Missouri-Columbia School of MedicineClass of 1981
Certifications & Licensure
MN State Medical License 1992 - 2024
IA State Medical License 1981 - 1994- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Clinical Trials
- S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease Start of enrollment: 2000 Apr 01
- Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer Start of enrollment: 1999 May 01
- Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202) Start of enrollment: 2004 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 11 citationsBreaking the Age Barrier: Physicians' Perceptions of Candidacy for Allogeneic Hematopoietic Cell Transplantation in Older Adults.Asmita Mishra, Jaime M. Preussler, Vijaya Raj Bhatt, Christopher Bredeson, Saurabh Chhabra, Anita D'Souza, Parastoo B. Dahi, Eileen Danaher Hacker, Lohith Gowda, Shahr...> ;Transplantation and Cellular Therapy. 2021 Apr 5
- 15 citationsLikelihood of Proceeding to Allogeneic Hematopoietic Cell Transplantation in the United States after Search Activation in the National Registry: Impact of Patient Age,...Jason Dehn, Pintip Chitphakdithai, Bronwen E. Shaw, Abby A. McDonald, Steven M. Devine, Linda J. Burns, Stephen R. Spellman> ;Transplantation and Cellular Therapy. 2021 Feb 1
- 9 citationsReturn-to-Work Guidelines and Programs for Post-Hematopoietic Cell Transplantation Survivors: An Initial SurveyRachel B. Salit, Stephanie J. Lee, Linda J. Burns, Bronwen E. Shaw, Navneet S. Majhail, Neel S Bhatt, William A. Wood, Karen L. Syrjala> ;Biology of Blood and Marrow Transplantation. 2020 Aug 1
- Join now to see all
Grant Support
- Mt2005-06-A Randomized Phase II Study Of Zolendronic Acid (ZOMETA) In The PrevenNational Center For Research Resources2007–2009
- 2008 Clinical Research Training Institute Summer WorkshopNational Heart, Lung, And Blood Institute2008
- Mt2005-14-Phase I OPEN Label, Single Arm, Dose Escalation Trial To Evaluate TheNational Center For Research Resources2008
- Mt2005-13-A Phase I OPEN Label, Single Arm, Dose Escalation Trial To Evaluate THNational Center For Research Resources2008
- Mt2005-14-A Phase I OPEN Label, Single Arm, Dose Escalation Trial To Evaluate THNational Center For Research Resources2007
- Mt2005-13-Phase I OPEN Label, Single Arm, Dose Escalation Trial To Evaluate TheNational Center For Research Resources2007
- Mt-2002-05-Post-Transplant Immunotherapy With Interleukin-2 (Il-2) And RituximabNational Center For Research Resources2007
- A Phase I OPEN Label, Single Arm, Dose Escalation Trial To Evaluate The BiodistrNational Center For Research Resources2006
- Post-Transplant Immunotherapy With Interleukin-2 (Il-2) And RituximabNational Center For Research Resources2004–2006
- A Phase I Study Of Ahn-12 In Patients With Advanced Leukemia/LymphomaNational Center For Research Resources2005
Hospital Affiliations
M Health Fairview University of Minnesota Medical CenterMinneapolis, Minnesota
